Evidence mapPaperPMID 41520082Full record

ArticleCommunications chemistry2026

Versatile introduction of multifunctional Michael-acceptor moieties on amino-oligonucleotides for bioconjugation purposes.

Jan H Meffert, Mónica Lopes, Enrico Cadoni, Martin Bollmark, Ulf Tedebark, Annemieke Madder

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jan H MeffertDepartment of Organic and Macromolecular Chemistry, Organic and Biomimetic Chemistry Research Group, Ghent University, Ghent, Belgium. jan.meffert@ugent.be.ORCID http://orcid.org/0000-0003-4342-5618
Mónica LopesSchool of Chemistry & Chemical Engineering and Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK.
Enrico CadoniDepartment of Organic and Macromolecular Chemistry, Organic and Biomimetic Chemistry Research Group, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0001-5585-7579
Martin BollmarkDepartment Chemical Process and Pharmaceutical Development, RISE, Södertälje, Sweden.ORCID http://orcid.org/0000-0002-3715-1959
Ulf TedebarkSynMer AB, Järfälla, Sweden.
Annemieke MadderDepartment of Organic and Macromolecular Chemistry, Organic and Biomimetic Chemistry Research Group, Ghent University, Ghent, Belgium. annemieke.madder@ugent.be.ORCID http://orcid.org/0000-0003-0179-7608

Funding

Bijzonder Onderzoeksfonds (Special Research Fund) BOF.BAS.2022.0023.01EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Grant Agreement No. 956070 (OLIGOMED)Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) FWO I006920N
6 · The paper itself

Abstract

The optimisation and further expansion of methods for the synthesis of oligonucleotide conjugates is receiving increased attention due to their importance for further advancement of therapeutic and diagnostic nucleic acid-based applications. Current methodologies, particularly those relying on maleimide-type linkers, are often hampered by linker instability. Herein, we present a versatile method for the direct functionalisation of readily available amino-modified oligonucleotides (AONs), where a 5-hydroxy-1,5-dihydro-2H-pyrrol-2-ones (5HP2O) Michael acceptor is directly formed in a rapid and efficient manner on a free primary amine. The methodology demonstrates broad applicability, tolerating various amino-modifiers and their positions within different oligonucleotide types, including DNA, LNA, PNA, and phosphorothioate-modified oligonucleotide strands. Most importantly, the possibility to introduce an additional second orthogonal reactive handle uniquely enables a direct single-site dual-functionalisation (Michael acceptor and click handle) of AONs for the assembly of complex constructs, as exemplified by the synthesis of a fluorescent peptide-oligonucleotide construct.

Identifiers

PMID41520082
PMCPMC12894876

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.